The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 19, 2016
Filed:
May. 28, 2014
Applicant:
Xeris Pharmaceuticals, Inc., Austin, TX (US);
Inventors:
Steven Prestrelski, San Diego, CA (US);
Kevin Brodbeck, Palo Alto, CA (US);
Assignee:
Xeris Pharmaceuticals, Inc., Austin, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/02 (2006.01); A61K 9/00 (2006.01); A61K 9/16 (2006.01); A61K 9/19 (2006.01); A61K 47/14 (2006.01); A61K 47/22 (2006.01); A61M 5/315 (2006.01); A61M 37/00 (2006.01); A61K 9/127 (2006.01); A61K 38/26 (2006.01); A61K 38/27 (2006.01); A61M 5/178 (2006.01); A61M 5/19 (2006.01); A61M 5/20 (2006.01); A61M 5/32 (2006.01); A61M 5/42 (2006.01); A61M 5/46 (2006.01); A61M 5/50 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0021 (2013.01); A61K 9/0014 (2013.01); A61K 9/127 (2013.01); A61K 9/16 (2013.01); A61K 9/1647 (2013.01); A61K 9/19 (2013.01); A61K 38/26 (2013.01); A61K 38/27 (2013.01); A61K 47/14 (2013.01); A61K 47/22 (2013.01); A61M 5/31513 (2013.01); A61M 5/31531 (2013.01); A61M 37/00 (2013.01); A61M 37/0069 (2013.01); A61M 5/1782 (2013.01); A61M 5/19 (2013.01); A61M 5/2033 (2013.01); A61M 5/2053 (2013.01); A61M 5/31548 (2013.01); A61M 5/31563 (2013.01); A61M 5/326 (2013.01); A61M 5/329 (2013.01); A61M 5/3234 (2013.01); A61M 5/3286 (2013.01); A61M 5/42 (2013.01); A61M 5/46 (2013.01); A61M 5/5086 (2013.01); A61M 2005/206 (2013.01); A61M 2005/2013 (2013.01); A61M 2005/2073 (2013.01); A61M 2205/59 (2013.01);
Abstract
Disclosed is a paste for injection of a therapeutic agent, the paste comprising an amount of powder comprising an effective amount of the therapeutic agent, wherein the powder is homogeneously contained within a pharmaceutically acceptable carrier, and wherein the paste comprises an injection volume of 0.1 to 3000 microliters.